missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EPB41L4B (aa 577-689) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (91%), Rat (91%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60150 (PA5-60150. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Up-regulates the activity of the Rho guanine nucleotide exchange factor ARHGEF18. Involved in the regulation of the circumferential actomyosin belt in epithelial cells (PubMed:22006950). Promotes cellular adhesion, migration and motility in vitro and may play a role in wound healing (PubMed:23664528). May have a role in mediating cytoskeletal changes associated with steroid-induced cell differentiation (PubMed:14521927). [UniProt]
Specifications
Specifications
| Accession Number | Q9H329 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 54566 |
| Name | Human EPB41L4B (aa 577-689) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 6430543G08Rik; AA589614; AU021054; band 4.1-like protein 4 B; BB007528; CG1; D4Ertd346e; Ehm2; Epb4.1l4b; EPB41L4B; erythrocyte membrane protein band 4.1 like 4 B; erythrocyte protein band 4.1 like 4 b; erythrocyte protein band 4.1-like 4 b; erythrocyte protein band 4.1-like 4 b; expressed in high-metastatic cells; expressed in high-metastatic cells; FERM-containing protein CG1; LULU2; Protein EHM2; RGD1562988 |
| Common Name | EPB41L4B |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction